Tazicef Injection, Powder, For Solution
Product Images NDC 0409-5086

5 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tazicef (NDC 0409-5086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Tazicef 01)

FDA Label Image

Structural Formula Ceftazidime (Tazicef 02)

Structural Formula Ceftazidime (Tazicef 02)
Chemical structure diagram of ceftazidime pentahydrate showing its molecular composition and arrangement, including the beta-lactam ring and side chains.*
FDA Label Image

Hospira Logo (Tazicef 03)

FDA Label Image

Principal Display Panel (6 gram Vial Label)

Principal Display Panel (6 gram Vial Label)
Label for TAZICEF (ceftazidime) injection powder for solution, 6 g per vial. The label indicates it is a pharmacy bulk multi-dose vial, not for direct infusion. Directions for intravenous use and reconstitution instructions are included. Manufactured by Hospira, Inc. The label also features dosage preparation details and storage information.*
FDA Label Image

Principal Display Panel (6 gram Vial Tray Label)

Principal Display Panel (6 gram Vial Tray Label)
Label for TAZICEF 6 g/vial Ceftazidime injection powder for solution, USP. It is a pharmacy bulk vial, not for direct infusion, containing 10 multiple-dose vials for intravenous use. The label states it is manufactured by Hospira, Inc., with storage instructions and reconstitution details included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.